About Visum Pharma
Visum Pharma is a private company based in Stamford, Connecticut, incorporated in 2021 in Delaware. It has reported $1,250,000 raised in two offerings on Form D since November 2021. Its chief executive is William Gedale.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 12, 2023 | Sep 13, 2023 | $50,000of $300K target | 1 | $50,000 | EquityRule 506(b), 4a5 | Form D ↗ |
| Oct 29, 2021 | Nov 2, 2021 | $1,200,000of $2.5M target | 1 | $1.2M | EquityRule 506(b), 4a5 | Form D ↗ |
| Total, two offerings | $1,250,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Visum Pharma's Form D filed Sep 13, 2023.
BP
Bernard Peperstraete
Director
PV
Peter Vanderklish
Director
JC
John Costantino
Director
AC
Alex Cuomo
Executive officer
WG
William Gedale
President and CEO, director
MS
Mark Smith
Executive officer